NIH to Use Horizon Discovery Gene Editing Tech in Stem Cell Studies | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery said today that the National Institutes of Health Center for Regenerative Medicine will use its genome editing technology in disease studies to discover how specific genes affect stem cells.

Under the technology access agreement, NIH CRM will use Horizon's Genesis technology to engineer stem cells to create isogenic disease models with specific induced mutations and lineage markers to understand the effects certain genes have on stem cells as they differentiate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.